Company / EPS (Diluted)
AETHLON MEDICAL INC EPS (Diluted) History
FY2014-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest EPS (Diluted)
-$5.86
FY2024
5-year range
-$5.86 / -$0.71
FY2020-FY2024
Trend
-725.4%
vs FY2023
Sector context
Sector data unavailable
Latest sector comparison
What the data says
EPS (Diluted) changed -725% YoY in FY2024, a notable deviation from the 8-year average annual change of -2100%.
Based on SEC 10-K filings.
-5.86 in FY2024.
Declined from $-1.87 to $-5.86 over the past 3 years.
EPS (Diluted) over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2024, eps (diluted) decreased 725.4% year-over-year.
- Peak eps (diluted) was recorded in FY2014.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -18.04 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | EPS (Diluted)Value | YoY GrowthYoY |
|---|---|---|
| FY2024 | -$5.86 | -725.4% |
| FY2023 | -$0.71 | - |
| FY2022 | - | - |
| FY2021 | -$1.87 | +63.5% |
| FY2020 | -$5.13 | -5030.0% |
| FY2018 | -$0.10 | +84.8% |
| FY2017 | -$0.66 | +45.9% |
| FY2016 | -$1.22 | +64.5% |
| FY2015 | -$3.44 | -11366.7% |
| FY2014 | -$0.03 | +62.5% |
As of FY2024 · SEC 10-K · Updated Jun 24, 2026